Mr. Brad S Koechle is a pharmacist who is specialized in Psychiatric in Springfield, Illinois. Patients can reach him at 401 N 4th St, Springfield or contact him on 217-299-2973. Active license number of Mr. Brad S Koechle is 051040085 for Psychiatric in Illinois. Mr. Brad S Koechle is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Complete Profile:
Mr. Brad S Koechle speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Mr. Brad S Koechle
Specialization:
Psychiatric
Gender:
Male
Location:
401 N 4th St, Springfield, Illinois, 62702-5205
Phone:
217-299-2973
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Mr. Brad S Koechle are as mentioned below.
NPI Number:
1841525847
NPI Enumeration Date:
08 Oct, 2009
NPI Last Update On:
08 Oct, 2009
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mr. Brad S Koechle are as mentioned below.
Specialization
License Number
State
Status
Psychiatric
051040085
Illinois
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
401 N 4th St, Springfield, Illinois
Zip:
62702-5205
Phone Number:
217-299-2973
Fax Number:
--
Patients can reach Mr. Brad S Koechle at 401 N 4th St, Springfield, Illinois or can call on phone at 217-299-2973.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.